The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s stem cell therapy market report forecasts the stem cell therapy market size to grow to $11.88 Billion by 2027, with a CAGR (compound annual growth rate) of more than 16%.

Learn More On The Stem Cell Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Stem Cell Therapy Market Size Forecast
The global stem cell therapy market is expected to grow from $5.14 billion in 2022 to $6.45 billion in 2023 at a compound annual growth rate (CAGR) of 25.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global stem cell therapy market size is expected to grow to $11.88 billion in 2027 at a CAGR of 16.5%.

North America held the largest stem cell therapy market share, and Middle East was the fastest-growing region in 2022.

Key Stem Cell Therapy Market Driver ­– Rise In The Prevalence Of Chronic Diseases
According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

Request for A Sample Of The Global Stem Cell Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Key Stem Cell Therapy Market Trend – Increasingly Investing In Strategic Partnerships
A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in June 2020, Shanghai Cell Therapy Group (SHCell) has recently begun a six-year research collaboration with Professor Qi-Long Ying of the University of Southern California (USC). The Ying laboratory hopes to develop conditions for long-term ex vivo expansion of mouse and human hematopoietic stem and progenitor cells through the project, which is supported by $3.6 million from the Baize Plan Fund.

Stem Cell Therapy Market Segment
1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
3) By Application: Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Other Applications
4) By End-User: Hospitals, Clinics

Stem Cell Therapy Market Major Players and Strategies
Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource.

In July 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Global Stem Cell Technology (GST) for an undisclosed amount. The acquisition completely supports Boehringer Ingelheim’s Animal Health strategy, which aims to improve its portfolio capabilities to spur innovation and growth. The purchase comes after a two-year, fruitful relationship that saw the introduction of the first-ever registered stem cell-based veterinary treatment to the European market. GST is a Belgian biotech company that develops and produces state-of-the art stem cell products for horses and pets.

The Stem Cell Therapy Global Market Report 2023 covers regional data on stem cell therapy market size, stem cell therapy market trends and drivers, opportunities, strategies, and stem cell therapy market competitor analysis. The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body’s natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells.

View More Reports Related To The Stem Cell Therapy Market –
Cell Therapy Global Market Report 2023
Stem Cell Global Market Report 2023
Stem Cell/Cord Blood Banking Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: